ADA. The GLP-1 receptor agonist exenatide (Byetta) was superior to glimepiride as an add-on therapy juni 11, 2012 2:44 e m Läs mer »
ADA reports on acute complications, genetic medicine, statins, MODY, incretins, beta cell regeneration juni 11, 2012 12:16 e m Läs mer »
Glargin (Lantus) Initiation after Metformin Achieved Superior Glycemic Control versus Sitagliptin in Type 2 Diabetes. EASIE. The Lancet juni 10, 2012 2:14 e m Läs mer »
Long-acting insulin degludec (Tresiba) slashes noctural hypoglycemia in study juni 10, 2012 2:05 e m Läs mer »
The Lancet diabetes ADA special issue online. DPPOS. Aggressive glucose-lowering treatments achieving normal glucose levels in people with prediabetes achieve maximum reductions 56% in progression to diabetes in the long-term juni 10, 2012 2:01 e m Läs mer »
Anti-Inflammatory Drug salicylate, Used for Thousands of Years, Now Found to Lower Blood Glucose Levels in People with Type 2 Diabet juni 10, 2012 1:48 e m Läs mer »
Children with Type 2 Diabetes Exhibit High Rates of Hypertension, Early Markers for Kidney Disease and Other Comorbidities (Today-study) juni 10, 2012 1:39 e m Läs mer »
